Millington, NJ, United States of America

Loretta Nielsen


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Loretta Nielsen: Innovator in Cancer Treatment

Introduction

Loretta Nielsen is a prominent inventor based in Millington, NJ (US). She has made significant contributions to the field of cancer treatment through her innovative research and development.

Latest Patents

Nielsen holds a patent for her invention titled "Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms." This invention provides methods for treating mammalian cancer or hyperproliferative cells. The method involves contacting these cells with a tumor suppressor protein or nucleic acid, along with at least one adjunctive anti-cancer agent. Additionally, the invention includes a pharmacological composition comprising a tumor suppressor protein or nucleic acid and an adjunctive anti-cancer agent, as well as a kit for the treatment of mammalian cancer or hyperproliferative cells. She has 1 patent to her name.

Career Highlights

Nielsen is associated with Canji Inc., where she continues to advance her research in cancer therapies. Her work is pivotal in developing new treatment methodologies that could potentially improve patient outcomes.

Collaborations

Some of her notable coworkers include Jo Ann Horowitz and Daniel C Maneval, who contribute to her research efforts and innovations.

Conclusion

Loretta Nielsen's work in cancer treatment exemplifies the impact of innovative thinking in medicine. Her contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…